Today's Reuters Health News Headlines - Yahoo! News: | | Analysis: Life saving lung cancer test to set off cost debate Wed,29 Jun 2011 03:07 PM PDT Reuters - NEW YORK (Reuters) - A landmark study showing that routine lung screening of heavy smokers and former smokers using low dose CT scans could save thousands of lives is sure to set off a fierce debate about the cost of such testing on an overburdened healthcare system. Full Story1 | Top | FDA panel rejects Avastin for breast cancer use Wed,29 Jun 2011 02:44 PM PDT Reuters - SILVER SPRING, Maryland (Reuters) - U.S. health advisers unanimously rejected use of the drug Avastin for breast cancer, dealing a blow to its manufacturer and patients who insisted that the medicine saved their lives.
Full Story1 | Top | Swine flu vaccine safe in pregnancy: study Wed,29 Jun 2011 02:39 PM PDT Reuters - NEW YORK (Reuters Health) - The swine flu shot appears to be safe for pregnant women, according to a new government report that tallies health problems occurring after the vaccinations. Full Story1 | Top | Pollutants linked to diabetes in new study Wed,29 Jun 2011 02:38 PM PDT Reuters - NEW YORK (Reuters Health) - People with higher levels of pesticides and other pollutants in their blood may be more likely to get type 2 diabetes, suggests a new study of elderly Swedes. Full Story1 | Top | Lundbeck won't pull drug used in U.S. executions Wed,29 Jun 2011 09:41 AM PDT Reuters - LONDON (Reuters) - Danish drugmaker Lundbeck will continue to sell a drug used in U.S. executions since pulling it off the market would be bad for some patients with severe epilepsy, its CEO said on Wednesday. Full Story1 | Top | Chronic pain costs U.S. up to $635 billion a year Wed,29 Jun 2011 08:06 AM PDT Reuters - WASHINGTON (Reuters) - Addressing chronic pain, a hard-to-treat yet highly common condition, costs the United States as much as $635 billion a year and requires a much more comprehensive strategy for curbing lost productivity and healthcare expenses, according to a new government report. Full Story1 | Top | Surgeons in Medtronic trials omitted results: report Tue,28 Jun 2011 04:26 PM PDT Reuters - NEW YORK (Reuters) - Surgeons conducting clinical trials to test a Medtronic Inc bone-growth protein used in spine surgery, some of whom got at least $62 million from the company, failed to report serious complications in their research papers, the Wall Street Journal reported. Full Story1 | Top | Aspirin might interfere with new heart drug Tue,28 Jun 2011 02:22 PM PDT Reuters - LONDON (Reuters) - A new study backs up a suggestion that high dosages of aspirin may interfere with AstraZeneca's heart drug Brilinta, offering a possible explanation for disappointing results from a study of patients in North America. Full Story1 | Top |
| | |
No comments:
Post a Comment